Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation - PubMed
Multicenter Study
doi: 10.1016/j.fertnstert.2013.01.109. Epub 2013 Feb 13.
Adriana Valentini, Ellen Greenblatt, Henry T Lynch, Parviz Ghadirian, Susan Armel, Susan L Neuhausen, Charmaine Kim-Sing, Nadine Tung, Beth Karlan, William D Foulkes, Ping Sun, Steven Narod; Hereditary Breast Cancer Study Group
Collaborators, Affiliations
- PMID: 23414920
- DOI: 10.1016/j.fertnstert.2013.01.109
Free article
Multicenter Study
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation
Amy Finch et al. Fertil Steril. 2013 May.
Free article
Abstract
Objective: To evaluate the impact of carrying a BRCA1 or BRCA2 mutation on the probability of experiencing premature natural menopause.
Design: Observational study.
Setting: Patients in an academic research environment.
Patient(s): Women who carry a BRCA1 or BRCA2 mutation (case subjects) and women who do not carry a mutation (control subjects).
Intervention(s): Survey about reproductive history administered on study entry and every 2 years thereafter.
Main outcome measure(s): The impact of carrying a BRCA mutation on age at menopause and other factors, including parity, age at first birth, age at last birth, and self-reported fertility.
Result(s): A total of 908 matched pairs were identified. The mean age at natural menopause was 48.8 years for BRCA1 carriers, 49.2 years for BRCA2 carriers, and 50.3 years for control subjects. Women who carried a BRCA mutation had parity similar to noncarriers and were as likely as noncarriers to have a child after age 35 years. Similar proportions reported a history of fertility problems (12.5% vs. 13.7%) and use of fertility medication (6.0% vs. 7.0%).
Conclusion(s): Women who carry a BRCA mutation experience menopause earlier, on average, than women who do not have a mutation, but the difference is small and does not appear to affect fertility.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Comment in
-
BRCA mutations and fertility: do not push the envelope!
Santoro N. Santoro N. Fertil Steril. 2013 May;99(6):1560. doi: 10.1016/j.fertnstert.2013.01.091. Epub 2013 Feb 4. Fertil Steril. 2013. PMID: 23380183 No abstract available.
Similar articles
-
Fertility in women with BRCA mutations: a case-control study.
Pal T, Keefe D, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Pal T, et al. Fertil Steril. 2010 Apr;93(6):1805-8. doi: 10.1016/j.fertnstert.2008.12.052. Epub 2009 Feb 6. Fertil Steril. 2010. PMID: 19200971
-
BRCA mutations and fertility: do not push the envelope!
Santoro N. Santoro N. Fertil Steril. 2013 May;99(6):1560. doi: 10.1016/j.fertnstert.2013.01.091. Epub 2013 Feb 4. Fertil Steril. 2013. PMID: 23380183 No abstract available.
-
McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group. McLaughlin JR, et al. Lancet Oncol. 2007 Jan;8(1):26-34. doi: 10.1016/S1470-2045(06)70983-4. Lancet Oncol. 2007. PMID: 17196508
-
BRCA 1, 2 mutation and earlier menopause: could BRCA 1,2 be used as predictor of menopause?
Nikolettos K, Damaskos C, Garmpis N, Nikolettos N. Nikolettos K, et al. Minerva Obstet Gynecol. 2022 Apr;74(2):165-170. doi: 10.23736/S2724-606X.21.04813-2. Epub 2021 Jun 17. Minerva Obstet Gynecol. 2022. PMID: 34137566 Review.
-
Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P. Casey MJ, et al. Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861. Gynecol Oncol. 2000. PMID: 10985881 Review.
Cited by
-
IVF for fertility preservation in breast cancer patients--efficacy and safety issues.
Shapira M, Raanani H, Meirow D. Shapira M, et al. J Assist Reprod Genet. 2015 Aug;32(8):1171-8. doi: 10.1007/s10815-015-0519-x. Epub 2015 Jul 1. J Assist Reprod Genet. 2015. PMID: 26126877 Free PMC article. Review.
-
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA, Collins IM, Milne RL, McLachlan SA, Friedlander M, Hickey M, Stern C, Hopper JL, Fisher R, Kannemeyer G, Picken S, Smith CD, Kelsey TW, Anderson RA; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab). Phillips KA, et al. Hum Reprod. 2016 May;31(5):1126-32. doi: 10.1093/humrep/dew044. Hum Reprod. 2016. PMID: 27094481 Free PMC article.
-
Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
van Lieshout LAM, Steenbeek MP, De Hullu JA, Vos MC, Houterman S, Wilkinson J, Piek JM. van Lieshout LAM, et al. Cochrane Database Syst Rev. 2019 Aug 28;8(8):CD012858. doi: 10.1002/14651858.CD012858.pub2. Cochrane Database Syst Rev. 2019. PMID: 31456223 Free PMC article.
-
Cordeiro Mitchell CN, McGuinness B, Fine E, Kearns WG, Christianson MS, Segars J, Pastore LM. Cordeiro Mitchell CN, et al. J Assist Reprod Genet. 2020 May;37(5):1037-1055. doi: 10.1007/s10815-020-01745-2. Epub 2020 Mar 24. J Assist Reprod Genet. 2020. PMID: 32212026 Free PMC article.
-
BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
Derks-Smeets IAP, van Tilborg TC, van Montfoort A, Smits L, Torrance HL, Meijer-Hoogeveen M, Broekmans F, Dreesen JCFM, Paulussen ADC, Tjan-Heijnen VCG, Homminga I, van den Berg MMJ, Ausems MGEM, de Rycke M, de Die-Smulders CEM, Verpoest W, van Golde R. Derks-Smeets IAP, et al. J Assist Reprod Genet. 2017 Nov;34(11):1475-1482. doi: 10.1007/s10815-017-1014-3. Epub 2017 Aug 22. J Assist Reprod Genet. 2017. PMID: 28831696 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous